Subhajit Dasgupta | Author | SciTechnol

Subhajit Dasgupta Author

sdasgupta@mail.sjsm.org 1-264-497-5125 | 1-264-497-51

Subjects of specialization
Multiple sclerosis; CD52; Lymphocytes; Monoclonal antibody; Alemtuzumab

Affiliation
Department of Microbiology, Immunology, and Department of Biochemistry, Saint James School of Medicine, Albert Lake Drive, The Quarter, A-I-2640, P.O Box 318, Anguilla BWI, Anguilla

Biography

Dr. Subhajit Dasgupta was an Assistant Professor of Department of Microbiology, Immunology, and Department of Biochemistry, Saint James School of Medicine, Albert Lake Drive, The Quarter, A-I-2640, P.O Box 318, Anguilla BWI, Anguilla and later he started his career in Prospect of CD52 Targeted Alemtuzumab in Treatment of CNS Demyelination in Multiple Sclerosis

Publications

Review Article Subscription

Prospect of CD52 Targeted Alemtuzumab in Treatment of CNS Demyelination in Multiple Sclerosis

Author(s):

Subhajit Dasgupta and Mausumi Bandyopadhyay

Prospect of CD52 Targeted Alemtuzumab in Treatment of CNS Demyelination in Multiple Sclerosis

The choice of humanized monoclonal antibody is a novel therapeutic approach for autoimmune relapsing remitting multiple sclerosis (RRMS). In addition to anti-alpha-4 integr in monoclonal antibody Natalizumab, introduction of CAMPATH-1 (Alemtuzumab) is a fairly new approach in MS research and clinical trials. The uniqueness of this monoclonal antibodyis that it d... view more»

DOI: 10.4172/2329-9541.1000131

Abstract HTML PDF